» Articles » PMID: 6205088

Exacerbation of Murine Cutaneous Leishmaniasis by Adoptive Transfer of Parasite-specific Helper T Cell Populations Capable of Mediating Leishmania Major-specific Delayed-type Hypersensitivity

Overview
Journal J Immunol
Date 1984 Sep 1
PMID 6205088
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of adoptive transfer of in vitro-propagated Leishmania major-specific T cell populations on the course of experimentally induced cutaneous leishmaniasis was studied in mice. The L. major-specific T cells expressed the T helper/inducer phenotype and were able in vitro to a) mount a specific proliferative response, b) provide specific helper activity for antibody responses, c) activate parasitized macrophages resulting in L. major destruction, and d) secrete macrophage-activating factors as tested in a tumoricidal assay. These T cells were also found capable of transferring parasite-specific delayed-type hypersensitivity responses to normal syngeneic mice. Results indicated that the i.v. transfer of these L. major-specific T cell populations into normal syngeneic mice exacerbated cutaneous lesions induced by infection with L. major. This effect on the disease process appeared to be dependent upon recognition of parasite antigens by the injected T cells because no exacerbation of the disease process was seen after the transfer of similar T cell populations specific for an antigen unrelated to the parasite, namely ovalbumin. However, the inclusion of ovalbumin in the L. major infecting inoculum resulted in an exacerbating effect of ovalbumin-specific T cells on cutaneous leishmaniasis. These unexpected results were supported by observations showing that immunization of mice with L. major antigens in complete Freund's adjuvant 7 days before infection with L. major led to exacerbated lesions. A similar aggravation of L. major-induced cutaneous lesions was also observed in mice previously immunized with an unrelated antigen provided that this antigen was included in the L. major infecting inoculum.

Citing Articles

Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model.

Wheat W, Arthun E, Spencer J, Regan D, Titus R, Dow S Vaccine. 2017; 35(48 Pt B):6611-6619.

PMID: 29079105 PMC: 5710984. DOI: 10.1016/j.vaccine.2017.10.039.


Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery.

Mendonca S Parasit Vectors. 2016; 9:492.

PMID: 27600664 PMC: 5013623. DOI: 10.1186/s13071-016-1777-x.


Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major.

Ngure P, Nganga Z, Kimutai A, Kepha S, Mongare S, Ingonga J Pan Afr Med J. 2014; 17 Suppl 1:15.

PMID: 24624248 PMC: 3946221. DOI: 10.11694/pamj.supp.2014.17.1.3638.


Immunomodulatory effects of the Lutzomyia longipalpis salivary gland protein maxadilan on mouse macrophages.

Brodie T, Smith M, Morris R, Titus R Infect Immun. 2007; 75(5):2359-65.

PMID: 17339357 PMC: 1865772. DOI: 10.1128/IAI.01812-06.


Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.

Theodos C, Morris R, Bishop J, Jones J, McMaster W, Titus R Infect Immun. 2004; 72(8):4486-93.

PMID: 15271907 PMC: 470630. DOI: 10.1128/IAI.72.8.4486-4493.2004.